Fondazione CDP announces the winning “In Sistema Ricerca” proposals

Fondazione CDP announces the winning “In Sistema Ricerca” proposals

Early diagnostics and innovative therapies: 12 winning projects in Fondazione CDP’s request for proposals in the field of healthcare.

Over one million initiatives selected in partnership with the Italian Ministry of Health, based on the Memorandum of Understanding signed in September 2023.

The resources will be earmarked for programmes already receiving funds under Italy’s National Resilience and Recovery Plan (NRRP).


The development of new instruments for early diagnostics, research into treatment and innovative systems for medical care are some of the objectives of the 12 projects awarded funding in the “In Sistema Ricerca” request for proposals, launched by Fondazione CDP with the Ministry of Health and dedicated to supporting research already receiving funding under the National Resilience and Recovery Plan.

The request for proposals, with over one million euros made available, will fund the work of research institutes (Research Hospitals), specialised hospitals and centres of excellence in medical care throughout Italy, selected after a rigorous evaluation process involving healthcare experts, including representatives from the Ministry of Health, as set out in the Memorandum of Understanding, signed between the Ministry and CDP Fondazione in September 2023.

The selected projects stand out for their considerable potential to make an impact in healthcare, from neurology to bioengineering, cardiology and oncology, from childhood to age-related diseases, including through the development of instruments for more effective, less invasive treatments.

Specifically, the following organisations and projects were chosen:

  • The Italian National Institute of Health, based in Rome, for the development of a remote platform assisting specialists in recognising the signs of autism.
  • Meyer University Hospital Trust, Florence, specialised in paediatric medicine, for the consolidation of data gathering on Dravet’s syndrome, a rare form of epilepsy.
  • San Raffaele Hospital, Milan, for research into treatments dedicated to neurodegenerative diseases such as Amyotrophic Lateral Sclerosis or Parkinson’s.
  • San Raffaele Hospital, Milan, for the development of systems to prevent respiratory diseases, also using Artificial Intelligence strategies.
  • Padova University Hospital Trust, for the development of innovative, non-invasive diagnostic methods for inflammatory bowel diseases, focussing in particular on children.
  • “Fondazione Giovanni Pascale” National Cancer Institute, Naples, for extending clinical trials on a vaccine for liver tumours.
  • Spedali Civili Hospital Trust, Brescia, for evaluation into the effectiveness of methods to combat pathological processes related to Alzheimer’s disease.
  • Fondazione Toscana Gabriele Monasterio Foundation, Pisa, for research into new approaches to coronary heart disease.
  • Bologna University Hospital Trust, for research on the effectiveness of liver transplants in the treatment of patients with hepatic carcinoma.
  • Monzino Cardiological Hospital, Milan, with a test project to evaluate the correlation between cardiac anomalies and neurological pathologies.
  • Verona University Hospital Trust, for the treatment of gastric tumours using an innovative sensor probe.
  • Galeazzi Hospital, Milan, for the development of innovative models to study pathologies affecting the spinal column.
The resources of the “In Sistema Ricerca” request for proposals will be dedicated to expenses other than those already funded by the NRRP - to support costs which are fundamental for the projects’ progress, including, for example, funds to involve patients’ associations and grants for research fellows, to guarantee more complete, longer-lasting funding.
“Thanks to the ‘In Sistema Ricerca’ request for proposals, we will be able to help support research projects that can make an impact on people and patients, improving their health, treatment and possibilities for care. The programmes, already considered strategic under the NRRP, will receive additional resources for their development. This will contribute to Italian scientific progress, empowering human capital and the expertise of people in the sector, and ensure funding that can extend beyond the deadlines set out in the Ministry of Health’s call”, commented Francesca Sofia, General Director of Fondazione CDP.